Related articles
-
NewsNative bacterial SynCom improves acidic soil and boosts lettuce growth
A synthetic community of two native soil bacteria helped reduce acidity and strongly boost lettuce growth in greenhouse experiments. Delivered on a sugarcane-processing residue, the microbes also increased nutrient availability and reshaped root-zone microbial activity.
-
NewsHidden microbial ecosystems of leatherback turtles offer new insights for Caribbean marine conservation
Scientists studying leatherback sea turtles in Puerto Rico have uncovered distinct microbial communities on the animals, their eggs, and the sand surrounding their nests.
-
NewsViral inflammation may disrupt the uterine lining and impair placental development
Viral infections early in pregnancy may disrupt the way the uterine lining prepares for implantation, with effects that can persist throughout pregnancy. In cell, mouse and 3D uterine models, researchers found that inflammation reduced decidualization and was linked to abnormal placental development and smaller fetuses.
More from News
-
NewsIndustrialisation may be reshaping the evolution of our gut bacteria
Gut bacteria living in industrialised societies appear to be evolving differently from those in non-industrialised populations. Researchers found that strains from industrialised hosts had recently acquired more genes, mostly through horizontal gene transfer, suggesting that modern lifestyles may be reshaping microbial evolution inside us.
-
NewsNew AI method spots outbreak signals in sparse and noisy data
A new early-warning method could help detect disease outbreaks even when case data are sparse, delayed or incomplete. By using topological data analysis to capture the underlying shape of epidemic time series, the system remained accurate even when up to half of the surveillance data were missing.
-
NewsCARB‑X–supported trivalent Salmonella vaccine advances to Phase 2 clinical trials
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) today announced that GSK’s global health vaccine program for a combined invasive nontyphoidal Salmonella and typhoid fever (iNTS‑TCV) has advanced into a Phase 2 clinical trial.
No comments yet